Manfred Beier - Concepedia

Author

Manfred Beier

Heinrich Heine University Düsseldorf ORCID

Also Known As

Beier, M., Beier, Manfred, M Beier, M. Beier, MANFRED BEIER, Manfred Beier, Richter, T.

Publications

924

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf Hospital Sant Joan de Déu Barcelona Center of Advanced European Studies and Research University of Duisburg-Essen Heidelberg University

About

Manfred Beier is an author at Heinrich Heine University Düsseldorf specializing in medicine, tumor biology, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	401
2	Cell Biology	4	4	263
3	Engineering	3	3	68
4	Health Sciences	1	1	11
5	Applied Physics	1	1	20

Manfred Beier

Publications

846

Citations

H-Index

Page 1

	Year	Citations
Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells Niels Eckstein, Kati Servan, Barbara Hildebrandt, Cancer Research Essential EventCancer BiologyTumor BiologyOvarian CancerPlatinum Resistance	2009	164
Twenty‐four new cases of <i>WT1</i> germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development Brigitte Royer‐Pokora, Manfred Beier, Markus Henzler, American Journal of Medical Genetics Part A	2004	156
Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm Brigitte Royer‐Pokora, Maike Busch, Manfred Beier, Human Molecular Genetics	2010	75
Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance Anne Thiel, Manfred Beier, Deborah Ingenhag, Leukemia Karyotype ImagingCytogeneticsMedicineGeneticsPrognostic Relevance	2011	64
Clinical relevance of mutations in the Wilms tumor suppressor 1 gene <i>WT1</i> and the cadherin‐associated protein β1 gene <i>CTNNB1</i> for patients with Wilms tumors Brigitte Royer‐Pokora, Angela Weirich, Valerié Schumacher, Cancer	2008	56
Reduction of the tumorigenic potential of human retinoblastoma cell lines by<i>TFF1</i>overexpression involves p53/caspase signaling and miR-18a regulation Maike Busch, Jan Große-Kreul, Janina Jasmin Wirtz, International Journal of Cancer Rb Cell ViabilityApoptosisImmunologyCell DeathDifferent Retinoblastoma	2017	48
Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH Christina Evers, Manfred Beier, Anne Poelitz, Genes Chromosomes and Cancer	2007	47
Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: Molecular mechanisms unveiled by gene expression profiling Martin Koch, Michaela L. Krieger, Daniel Philipp Stölting, Biochemical Pharmacology Chemotherapy ResistanceLiposomal CisplatinMedicineCancer GenomicsCancer Biology	2013	40
Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia Detlef Trost, Barbara Hildebrandt, Manfred Beier, Cancer Genetics and Cytogenetics Karyotype ImagingChromatinHematological MalignancyEngineeringCytogenetics	2006	36
TFF1 in Aqueous Humor—A Potential New Biomarker for Retinoblastoma Maike Busch, André Haase, Natalia Miroschnikov, Cancers Tumor BiologyOcular DiseaseOphthalmologyMedicinePathology	2022	27

Page 1